What is the pipeline for future medications for obesity? International Journal of Obesity Glucagon like peptide 1 (GLP 1) receptor agonists are incretin analogues that promote glucose mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP 1 receptor agonists and GLP 1 and glucose dependent insulinotropic Glucagon like peptide 1 receptor: mechanisms and advances in therapy Signal Transduction and Targeted Therapy Full article: Oral glucagon like peptide 1 receptor agonists and combinations of entero pancreatic hormones as treatments for adults with type 2 diabetes: where are we now? Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research News & Announcements Cayman Chemical